424 related articles for article (PubMed ID: 19037963)
1. Comparison of cysteinyl leukotriene concentrations between exhaled breath condensate and bronchoalveolar lavage fluid.
Ono E; Mita H; Taniguchi M; Higashi N; Tsuburai T; Miyazaki E; Kumamoto T; Akiyama K
Clin Exp Allergy; 2008 Dec; 38(12):1866-74. PubMed ID: 19037963
[TBL] [Abstract][Full Text] [Related]
2. Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis.
Piotrowski WJ; Antczak A; Marczak J; Nawrocka A; Kurmanowska Z; Górski P
Chest; 2007 Aug; 132(2):589-96. PubMed ID: 17573522
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis.
Rozy A; Czerniawska J; Stepniewska A; Woźbińska B; Goljan A; Puścińska E; Górecka D; Chorostowska-Wynimko J
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():335-40. PubMed ID: 17072062
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.
Carraro S; Corradi M; Zanconato S; Alinovi R; Pasquale MF; Zacchello F; Baraldi E
J Allergy Clin Immunol; 2005 Apr; 115(4):764-70. PubMed ID: 15805996
[TBL] [Abstract][Full Text] [Related]
5. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis.
Psathakis K; Mermigkis D; Papatheodorou G; Loukides S; Panagou P; Polychronopoulos V; Siafakas NM; Bouros D
Eur J Clin Invest; 2006 May; 36(5):362-7. PubMed ID: 16634841
[TBL] [Abstract][Full Text] [Related]
6. Levels of cysteinyl-leukotrienes in exhaled breath condensate are not due to saliva contamination.
Tufvesson E; van Weele LJ; Ekedahl H; Bjermer L
Clin Respir J; 2010 Apr; 4(2):83-8. PubMed ID: 20565481
[TBL] [Abstract][Full Text] [Related]
7. Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations.
Czebe K; Barta I; Antus B; Valyon M; Horváth I; Kullmann T
Respir Med; 2008 May; 102(5):720-5. PubMed ID: 18249106
[TBL] [Abstract][Full Text] [Related]
8. Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate.
Leung TF; Li CY; Yung E; Liu EK; Lam CW; Wong GW
Pediatr Pulmonol; 2006 Jan; 41(1):87-94. PubMed ID: 16292777
[TBL] [Abstract][Full Text] [Related]
9. [Markers of fibrosis and inflammation in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis -- a pilot study].
Kowalska A; Puścińska E; Czerniawska J; Goljan-Geremek A; Czystowska M; Rozy A; Chorostowska-Wynimko J; Górecka D
Pneumonol Alergol Pol; 2010; 78(5):356-62. PubMed ID: 20703999
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor in exhaled breath and BAL fluid in sarcoidosis.
Piotrowski WJ; Kurmanowska Z; Antczak A; Marczak J; Górski P
Pneumonol Alergol Pol; 2010; 78(3):187-91. PubMed ID: 20461686
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage.
Jackson AS; Sandrini A; Campbell C; Chow S; Thomas PS; Yates DH
Am J Respir Crit Care Med; 2007 Feb; 175(3):222-7. PubMed ID: 17110649
[TBL] [Abstract][Full Text] [Related]
12. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity.
Samitas K; Chorianopoulos D; Vittorakis S; Zervas E; Economidou E; Papatheodorou G; Loukides S; Gaga M
Respir Med; 2009 May; 103(5):750-6. PubMed ID: 19110408
[TBL] [Abstract][Full Text] [Related]
13. Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate.
Antczak A; Piotrowski W; Marczak J; Ciebiada M; Gorski P; Barnes PJ
Dis Markers; 2011; 30(5):213-20. PubMed ID: 21734340
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation.
Aggarwal S; Moodley YP; Thompson PJ; Misso NL
Clin Exp Allergy; 2010 Jan; 40(1):85-93. PubMed ID: 19895589
[TBL] [Abstract][Full Text] [Related]
15. Mechanical ventilation induces changes in exhaled breath condensate of patients without lung injury.
Roca O; Gómez-Ollés S; Cruz MJ; Muñoz X; Griffiths MJ; Masclans JR
Respir Med; 2010 Jun; 104(6):822-8. PubMed ID: 20138493
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma.
Jungraithmayr W; Frings C; Zissel G; Prasse A; Passlick B; Stoelben E
Respirology; 2008 Nov; 13(7):1022-7. PubMed ID: 18764914
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between cysteinyl leukotriene in exhaled breath condensate and the severity of asthma in adult asthmatics in Japan].
Tsuburai T; Mita H; Tsurikisawa N; Oshikata C; Ono E; Fukutomi Y; Tanimoto H; Sekiya K; Otomo M; Maeda Y; Taniguchi M; Ikehara K; Akiyama K
Arerugi; 2008 Feb; 57(2):121-9. PubMed ID: 18349586
[TBL] [Abstract][Full Text] [Related]
18. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma.
Kiełbasa B; Moeller A; Sanak M; Hamacher J; Hutterli M; Cmiel A; Szczeklik A; Wildhaber JH
Pediatr Allergy Immunol; 2008 Nov; 19(7):660-9. PubMed ID: 18643946
[TBL] [Abstract][Full Text] [Related]
19. [Exhaled breath condensate in the assessment of airway inflammation].
Skiepko R; Zietkowski Z; Tomasiak MM; Bodzenta-Lukaszyk A
Przegl Lek; 2006; 63(12):1321-5. PubMed ID: 17642149
[TBL] [Abstract][Full Text] [Related]
20. Urea in exhaled breath condensate of uraemics and patients with chronic airway diseases.
Folesani G; Corradi M; Goldoni M; Manini P; Acampa O; Andreoli R; Bertorelli G; David S; Franchini I
Acta Biomed; 2008; 79 Suppl 1():79-86. PubMed ID: 18924313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
